SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018839
Filing Date
2023-05-08
Accepted
2023-05-08 16:21:14
Documents
51
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q oric-20230331.htm   iXBRL 10-Q 2412001
2 EX-31.1 oric-ex31_1.htm EX-31 21184
3 EX-31.2 oric-ex31_2.htm EX-31 21170
4 EX-32.1 oric-ex32_1.htm EX-32 11960
5 EX-32.2 oric-ex32_2.htm EX-32 11946
  Complete submission text file 0000950170-23-018839.txt   7445007

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oric-20230331_cal.xml EX-101.CAL 32243
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oric-20230331_def.xml EX-101.DEF 143961
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oric-20230331_lab.xml EX-101.LAB 370506
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oric-20230331_pre.xml EX-101.PRE 257720
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oric-20230331.xsd EX-101.SCH 37586
45 EXTRACTED XBRL INSTANCE DOCUMENT oric-20230331_htm.xml XML 1338340
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39269 | Film No.: 23898067
SIC: 2834 Pharmaceutical Preparations